Skip to header Skip to main content Skip to footer

For Healthcare Professionals

Home
Slide Library
Events
Videos
- Steering Committee
- Mission Statement

Search for slide modules, events, videos...

Search

Welcome To ACROSS T2D

ACROSS T2D is the global Academy for Cardiovascular Risks, Outcomes and Safety Studies in Type 2 Diabetes (T2D).

Backed by our globally renowned STEERING COMMITTEE, the ACROSS T2D programme provides up-to-date, scientifically robust tools and information to support our multidisciplinary colleagues involved in the management of type 2 diabetes.

What’s New

Overweight patient diagnosed with T2D

Patient Case Study - Overweight patient diagnosed with T2D

Patient with acute myocardial infarction

Patient Case Study - Patient with acute myocardial infarction

SGLT2-inhebitors-cvots-and-kidney-outcome-trial

Kidney outcomes in SGLT2 inhibitor outcome trials in patients with T2D

diabetic-kidney-disease-teaser

Diabetes and COVID-19

Primary Care Diabetes Europe SGLT2 Inhibitors

Use of SGLT2 inhibitors in primary care

cardio-renal-matabolic-teaser

Understanding the interrelated CRM systems

diabetic-kidney-disease-teaser

Patient Case Study: Patient with Peripheral Artery Disease at Risk of CV Events

Stay Up to Date - Subscribe to our newsletter

Slide Library

DISEASE STATE - View all modules

THERAPEUTIC MANAGEMENT - View all modules

CARDIOVASCULAR OUTCOMES TRIALS - View all modules

Videos

MECHANISM OF ACTION OF SGLT2 INHIBITORS

Mechanism of Action of SGLT2 Inhibitors

September 28, 2020

PRACTICAL MANAGEMENT OF PATIENTS TAKING SGLT2 INHIBITORS

Practical Management of Patients Taking SGLT2 Inhibitors

September 28, 2020

EXPLORING THE HEALTH ECONOMIC IMPLICATIONS OF SGLT2 INHIBITORS

Exploring the Health Economic Implications of SGLT2 Inhibitors

September 28, 2020

Events

21 - 25 September

EUROPEAN ASSOCIATION FOR THE STUDY OF DIABETES 2020

Vienna, Austria

16 - 20 September

EUROPEAN ASSOCIATION FOR THE STUDY OF DIABETES 2019

FIRA DE BARCELONA, BARCELONA, SPAIN

Imprint
Privacy Statement
Terms of Use
Contact

©2020 Boehringer Ingelheim International GmbH. All rights reserved.